141 related articles for article (PubMed ID: 37119282)
1. Topical steroid withdrawal: an emerging clinical problem.
Brookes TS; Barlow R; Mohandas P; Bewley A
Clin Exp Dermatol; 2023 Aug; 48(9):1007-1011. PubMed ID: 37119282
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
3. Cessation of Long-term Topical Steroids in Adult Atopic Dermatitis: A Prospective Cohort Study.
Sheary B; Harris MF
Dermatitis; 2020; 31(5):316-320. PubMed ID: 32404621
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL;
J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622
[TBL] [Abstract][Full Text] [Related]
5. Steroid Withdrawal Effects Following Long-term Topical Corticosteroid Use.
Sheary B
Dermatitis; 2018; 29(4):213-218. PubMed ID: 29923852
[TBL] [Abstract][Full Text] [Related]
6. Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp.
Kastarinen H; Oksanen T; Okokon EO; Kiviniemi VV; Airola K; Jyrkkä J; Oravilahti T; Rannanheimo PK; Verbeek JH
Cochrane Database Syst Rev; 2014 May; 2014(5):CD009446. PubMed ID: 24838779
[TBL] [Abstract][Full Text] [Related]
7. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
8. Topical corticosteroid withdrawal ('steroid addiction'): an update of a systematic review.
Hwang J; Lio PA
J Dermatolog Treat; 2022 May; 33(3):1293-1298. PubMed ID: 33499686
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.
Hussain Z; Sahudin S; Thu HE; Shuid AN; Bukhari SN; Kumolosasi E
Crit Rev Ther Drug Carrier Syst; 2016; 33(3):213-263. PubMed ID: 27910751
[TBL] [Abstract][Full Text] [Related]
10. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
Kircik LH; Del Rosso JQ
J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
[TBL] [Abstract][Full Text] [Related]
11. Emerging Treatment Options in Atopic Dermatitis: Topical Therapies.
Nygaard U; Deleuran M; Vestergaard C
Dermatology; 2017; 233(5):333-343. PubMed ID: 29216643
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
Broeders JA; Ahmed Ali U; Fischer G
J Am Acad Dermatol; 2016 Aug; 75(2):410-419.e3. PubMed ID: 27177441
[TBL] [Abstract][Full Text] [Related]
13. Topical steroid withdrawal: a survey of UK dermatologists' attitudes.
Barlow R; Proctor A; Moss C
Clin Exp Dermatol; 2024 May; 49(6):607-611. PubMed ID: 38320214
[TBL] [Abstract][Full Text] [Related]
14. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
Draelos ZD
Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
[TBL] [Abstract][Full Text] [Related]
15. Topical Steroid Withdrawal: A Case Series of 10 Children.
Sheary B
Acta Derm Venereol; 2019 May; 99(6):551-556. PubMed ID: 30734047
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
17. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis.
Furue M; Terao H; Rikihisa W; Urabe K; Kinukawa N; Nose Y; Koga T
Br J Dermatol; 2003 Jan; 148(1):128-33. PubMed ID: 12534606
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
[TBL] [Abstract][Full Text] [Related]
19. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
[TBL] [Abstract][Full Text] [Related]
20. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
